Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
EROAD (ERD) / FY25

FCF rose to $16.0m but operating cash conversion fell to 72.5%

Capex fell 58.4% as the 4G program rolled off, but OCF/EBITDA dropped from 99.2% to 72.5% even as EBITDA grew to $59.6m.

Technology / Transport software

ERD revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $195.2m, versus $99.1m in HY26.

ERD EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • FY25 ERD: Outside range high ebitda margin. 30.7%; 3-period range 20% to 29.3%. EBITDA margin: 30.7%, above normal range; 3-period mean 25.0%, range 20.0%-29.3%.
  • FY26 ERD: Outside range low ebitda margin. 20%; 3-period range 25.8% to 30.7%. EBITDA margin: 20.0%, below normal range; 3-period mean 28.6%, range 25.8%-30.7%.
EBITDA margin: 20.0%, below normal range; 3-period mean 28.6%, range 25.8%-30.7%.

ERD operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $30.3m, versus $25.7m in HY26.

ERD working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • FY23 ERD: Outside range low operating working-capital movement. $-7.4m; 3-period range $0m to $0m. Operating working-capital movement: NZ$-7.4m, below normal range; 0/3 prior periods had builds, and none had a working-capital release.
Operating working-capital movement: NZ$-7.4m, below normal range; 0/3 prior periods had builds, and none had a working-capital release.
Release date
26 May 2025
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY25 vs FY24

Revenue

$194.4m

+6.8% ↑ vs $182m

EBITDA

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net profit after tax

$0m

flat vs $0m

Net cash inflow from operating activities

$43.2m

-18.3% ↓ vs $52.9m

Operating profit

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Profit before tax

$0m

flat vs $0m

Cash and cash equivalents

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

$460.3m

+6.2% ↑ vs $433.5m

What changed

Operating cash conversion fell from 99.2% to 72.5% as net cash from operations declined to $43.2m from $52.9m even though EBITDA rose to $59.6m from $53.3m — which means the 12x lift in reported free cash flow to $16.0m is a capex-cycle outcome, not an earnings-quality outcome

Capex fell 58.4% to $13.4m (6.9% of revenue, down from 17.7%) as the 4G upgrade program normalised.

On the operating line, revenue rose 6.8% to $194.4m and the group swung to a $1.4m NPAT (FY24: $0.3m loss) and $0.2m PBT (FY24: $7.0m loss). The NPAT line is flattered by a roughly $1.2m net tax credit, so PBT is the cleaner read on operating progress.

Net debt dropped to $11.8m from $22.1m, taking net debt/EBITDA to 0.20x from 0.41x.

What matters

Reported FCF improvement is capex-driven, not operating-driven

FCF rose $14.7m year-on-year, but capex fell $18.8m while OCF fell $9.7m. The post-4G normalised capex run-rate is the more important number for valuing the business than the FY25 print, and management has not provided an FY26 capex guide in the supplied materials.

Operating cash conversion deteriorated despite EBITDA growth. OCF/EBITDA at 72.5% is roughly 27 percentage points below FY24's 99.2%. Receivable days improved modestly to 47.5 from 50.7, so a debtor build alone does not explain the gap — investors need clarity on which working-capital or non-cash items absorbed cash.

North America segment result fell 19.5% on revenue up 1.5%. The second-largest geography saw segment result drop to $17.7m from $22.0m. New Zealand (+13% revenue, +12.5% result) is carrying group performance and rose to 38.3% of revenue from 35.7%. North America margin trajectory is now the key segment question.

Expectations

No forward financial targets are supplied

Management states it delivered to the top end of, or exceeded, guidance on all key measures, but the specific FY25 guidance bands and any FY26 outlook are not detailed in the supplied excerpts.

HY25 revenue of $95.9m represented 49.3% of the full-year figure, so phasing was broadly even rather than second-half loaded. With the 4G upgrade program rolling off, the absence of an explicit FY26 capex guide is the most material shape variable — any return to elevated capex would unwind much of the FCF improvement that headlined this release.

Quality of result

Durable elements include revenue growth of 6.8%, EBITDA expansion to $59.6m, lower leverage at net debt/EBITDA of 0.20x (vs 0.41x), and the swing to positive PBT and NPAT

The capital-structure improvement is genuine and improves financial flexibility regardless of how cash flows trend from here.

Less durable is the FCF print. The 12x year-on-year jump is largely a capex base effect — the $18.8m drop in PP&E investment swamps the $9.7m decline in operating cash flow. Cash conversion of 72.5% versus 99.2% prior implies working-capital or non-cash timing items absorbed cash as EBITDA rose; receivable days fell to 47.5 from 50.7, so debtor movement is not the explanation. NPAT of $1.4m on equity of $331.7m delivers ROE of 0.4%, which means absolute earnings power remains thin relative to the asset base, and that NPAT was supported by a tax credit. The headline FCF figure is best treated as a transition-year outcome rather than a steady-state run rate.

Unresolved

Open questions

What explains OCF falling $9.7m while EBITDA rose $6.3m, given receivable days improved?
Why did the North America segment result fall 19.5% to $17.7m on revenue up only 1.5%?
What is the post-4G normalised capex run-rate, and will FY26 capex stay near 7% of revenue?
How does management plan to translate $59.6m of EBITDA into a materially higher NPAT and ROE in FY26?
Why is the effective tax position a net credit this year, and is that repeatable?

This briefing cannot assess whether the FY25 cash-conversion fall reflects a one-period working-capital or timing effect or a structural change in how revenue translates into operating cash flow.

Chat

Ask about ERD FY25

Ask follow-up questions about EROAD's FY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about ERD FY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about EROAD's FY25 result.

What explains OCF falling $9.7m while EBITDA rose $6.3m, given receivable days improved?Why does "Reported FCF improvement is capex-driven, not operating-driven" matter?How strong was the cash and earnings quality in FY25?What should I watch next for ERD after FY25?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

EROAD FY25 Annual Report

FY25 / financial report↗

EROAD FY25 Investor Presentation

FY25 / results presentation↗

EROAD FY25 Market Release

FY25 / results release↗

EROAD FY25 Results Announcement

FY25 / results announcement↗

Prior comparable period

EROAD FY24 Annual Report

FY24 / financial report↗

EROAD FY24 Market Release

FY24 / results release↗

EROAD FY24 Results Announcement

FY24 / results announcement↗

Interim context

EROAD H1 FY25 Interim Report

HY25 / financial report↗

EROAD H1 FY25 Market Release

HY25 / results release↗

EROAD H1 FY25 Results Announcement

HY25 / results announcement↗

Release context

EROAD H1 FY25 Investor Presentation

FY25 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 72.5% of EBITDA to operating cash flow, -26.8pp versus the prior comparable period.

→

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 0.20x, -0.22x versus the prior comparable period.

→

Revenue growth context

Revenue growth was 6.8% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when ERD publishes next

Get the next EROAD briefing and related NZX reporting-season updates by email.